May 17, 2021. We support the “I” rating that there is insufficient evidence to assess the benefits and harms of screening for atrial fibrillation in asymptomatic adults ages 50 and over.
Read More »Tag: atrial fibrillation
NCHR’s Public Comments on the USPSTF Draft Research Plan on Atrial Fibrillation: Screening With Electrocardiography
April 22, 2020: We commend the assessment of the potential benefits and harms of electrocardiography screening among asymptomatic adults. Furthermore, we applaud the commitment to assessing these potential benefits and harms by subgroups defined by stroke risk, as well as by race/ethnicity, age, and sex.
Read More »Which Blood-Thinning Medication Is Right for You?
This article will describe the benefits and risks of different blood thinning medications for reducing the chance of stroke for those with atrial fibrillation.
Read More »